Correlation Between SAB Biotherapeutics and NLS Pharmaceutics
Can any of the company-specific risk be diversified away by investing in both SAB Biotherapeutics and NLS Pharmaceutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining SAB Biotherapeutics and NLS Pharmaceutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between SAB Biotherapeutics and NLS Pharmaceutics AG, you can compare the effects of market volatilities on SAB Biotherapeutics and NLS Pharmaceutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in SAB Biotherapeutics with a short position of NLS Pharmaceutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of SAB Biotherapeutics and NLS Pharmaceutics.
Diversification Opportunities for SAB Biotherapeutics and NLS Pharmaceutics
-0.75 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between SAB and NLS is -0.75. Overlapping area represents the amount of risk that can be diversified away by holding SAB Biotherapeutics and NLS Pharmaceutics AG in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on NLS Pharmaceutics and SAB Biotherapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on SAB Biotherapeutics are associated (or correlated) with NLS Pharmaceutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of NLS Pharmaceutics has no effect on the direction of SAB Biotherapeutics i.e., SAB Biotherapeutics and NLS Pharmaceutics go up and down completely randomly.
Pair Corralation between SAB Biotherapeutics and NLS Pharmaceutics
Assuming the 90 days horizon SAB Biotherapeutics is expected to generate 3.51 times more return on investment than NLS Pharmaceutics. However, SAB Biotherapeutics is 3.51 times more volatile than NLS Pharmaceutics AG. It trades about 0.15 of its potential returns per unit of risk. NLS Pharmaceutics AG is currently generating about -0.02 per unit of risk. If you would invest 5.26 in SAB Biotherapeutics on September 1, 2024 and sell it today you would earn a total of 1.49 from holding SAB Biotherapeutics or generate 28.33% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Weak |
| Accuracy | 90.48% |
| Values | Daily Returns |
SAB Biotherapeutics vs. NLS Pharmaceutics AG
Performance |
| Timeline |
| SAB Biotherapeutics |
| NLS Pharmaceutics |
SAB Biotherapeutics and NLS Pharmaceutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with SAB Biotherapeutics and NLS Pharmaceutics
The main advantage of trading using opposite SAB Biotherapeutics and NLS Pharmaceutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if SAB Biotherapeutics position performs unexpectedly, NLS Pharmaceutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in NLS Pharmaceutics will offset losses from the drop in NLS Pharmaceutics' long position.| SAB Biotherapeutics vs. SAB Biotherapeutics | SAB Biotherapeutics vs. Jasper Therapeutics | SAB Biotherapeutics vs. NRx Pharmaceuticals |
| NLS Pharmaceutics vs. Neurobo Pharmaceuticals | NLS Pharmaceutics vs. Indaptus Therapeutics | NLS Pharmaceutics vs. Pasithea Therapeutics Corp | NLS Pharmaceutics vs. Quoin Pharmaceuticals Ltd |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Economic Indicators module to top statistical indicators that provide insights into how an economy is performing.
Other Complementary Tools
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume |